Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Long-term clinical outcomes following coronary stenting.

Anstrom KJ, Kong DF, Shaw LK, Califf RM, Kramer JM, Peterson ED, Rao SV, Matchar DB, Mark DB, Harrington RA, Eisenstein EL.

Arch Intern Med. 2008 Aug 11;168(15):1647-55. doi: 10.1001/archinte.168.15.1647.

PMID:
18695078
2.

Coronary artery stents: a rapid systematic review and economic evaluation.

Hill R, Bagust A, Bakhai A, Dickson R, Dündar Y, Haycox A, Mujica Mota R, Reaney A, Roberts D, Williamson P, Walley T.

Health Technol Assess. 2004 Sep;8(35):iii-iv, 1-242. Review.

3.

Clinical outcomes of dialysis patients after implantation of DES: meta analysis and systematic review of literature.

Athappan G, Ponniah T.

Minerva Cardioangiol. 2009 Jun;57(3):291-7. Review.

PMID:
19513010
4.

[Drug-eluting stents for diabetic patients. A critical appraisal of the currently available data from randomized trials].

Silber S, Herdeg C.

Herz. 2008 Apr;33(3):196-205. doi: 10.1007/s00059-008-3121-5. Review. German.

PMID:
18568314
5.

Use of drug-eluting stents in acute myocardial infarction: a systematic review and meta-analysis.

Brar SS, Leon MB, Stone GW, Mehran R, Moses JW, Brar SK, Dangas G.

J Am Coll Cardiol. 2009 May 5;53(18):1677-89. doi: 10.1016/j.jacc.2009.03.013. Review.

6.

A collaborative systematic review and meta-analysis on 1278 patients undergoing percutaneous drug-eluting stenting for unprotected left main coronary artery disease.

Biondi-Zoccai GG, Lotrionte M, Moretti C, Meliga E, Agostoni P, Valgimigli M, Migliorini A, Antoniucci D, Carrié D, Sangiorgi G, Chieffo A, Colombo A, Price MJ, Teirstein PS, Christiansen EH, Abbate A, Testa L, Gunn JP, Burzotta F, Laudito A, Trevi GP, Sheiban I.

Am Heart J. 2008 Feb;155(2):274-83. doi: 10.1016/j.ahj.2007.10.009. Epub 2007 Nov 26. Review.

PMID:
18215597
7.

Drug-eluting stents versus bare-metal stents in diabetic patients with ST-segment elevation acute myocardial infarction: a pooled analysis of individual patient data from seven randomized trials.

Iijima R, Byrne RA, Dibra A, Ndrepepa G, Spaulding C, Laarman GJ, Menichelli M, Valgimigli M, Di Lorenzo E, Kaiser C, Tierala I, Mehilli J, Suttorp MJ, Violini R, Schömig A, Kastrati A.

Rev Esp Cardiol. 2009 Apr;62(4):354-64. Review. English, Spanish.

8.

Clinical impact of sirolimus-eluting stent in ST-segment elevation myocardial infarction: a meta-analysis of randomized clinical trials.

Piscione F, Piccolo R, Cassese S, Galasso G, Chiariello M.

Catheter Cardiovasc Interv. 2009 Aug 1;74(2):323-32. doi: 10.1002/ccd.22017. Review.

PMID:
19360858
9.

The costs and quality-of-life outcomes of drug-eluting coronary stents: a systematic review.

Groeneveld PW, Suh JJ, Matta MA.

J Interv Cardiol. 2007 Feb;20(1):1-9. Review.

PMID:
17300390
10.

[Drug-eluting stents: from the results of clinical studies to economic simulation models in the Italian reality].

Sangiorgi G, Rodamni P, Airoldi F, Colombo A.

Ital Heart J Suppl. 2005 Mar;6(3):145-56. Review. Italian.

PMID:
15875500
11.

Use of drug-eluting stents in saphenous vein aortocoronary bypass graft lesions: a critical appraisal.

Brilakis ES, Saeed B, Banerjee S.

J Interv Cardiol. 2008 Apr;21(2):151-7. doi: 10.1111/j.1540-8183.2007.00341.x. Epub 2008 Feb 28. Review.

PMID:
18312303
12.

Drug-eluting stents in patients with end-stage renal disease.

Weathers LW, Ziada KM.

Minerva Cardioangiol. 2008 Feb;56(1):117-25. Review.

PMID:
18432174
13.

Evidence-based treatment of unprotected left main disease: a critical review of the literature.

Sharis P, Shammas NW.

Curr Atheroscler Rep. 2007 Nov;9(5):397-400. Review.

PMID:
18001623
14.

Multivessel disease: percutaneous coronary intervention for classic coronary artery bypass grafting indications.

Brar SS, Syros G, Dangas G.

Angiology. 2008 Apr-May;59(2 Suppl):83S-8S. doi: 10.1177/0003319708318862. Epub 2008 Jun 10. Review.

PMID:
18544582
15.

Coronary artery disease.

McCullough PA.

Clin J Am Soc Nephrol. 2007 May;2(3):611-6. Epub 2007 Mar 21. Review.

16.

Diabetic endovascular disease: role of coronary artery revascularization.

Stone KE, Chiquette E, Chilton RJ.

Am J Cardiol. 2007 Feb 19;99(4A):105B-112B. Epub 2006 Dec 22. Review.

PMID:
17307063
17.

Diabetes mellitus and coronary artery disease: therapeutic considerations.

Ghosh J, Weiss MB, Kay RH, Frishman WH.

Heart Dis. 2003 Mar-Apr;5(2):119-28. Review.

PMID:
12713679
18.

[Percutaneous coronary intervention in diabetes mellitus: an updated analysis of medical practice].

Quadros A, Diemer F, Lima T, Abdalla R, Vizotto M, Gottschall CA, Schaan BD.

Arq Bras Endocrinol Metabol. 2007 Mar;51(2):327-33. Review. Portuguese.

19.
20.

[Cardiovascular ageing and ethics].

Fournier V.

Arch Mal Coeur Vaiss. 2006 Nov;99 Spec No 4:25-8. Review. French.

PMID:
17236466

Supplemental Content

Support Center